In a groundbreaking development for glaucoma treatment, Avisi Technologies has shared promising results from their VITA Trial involving the innovative VisiPlate® device. Conducted across three medical centers in South Africa, this pilot study showcases the safety and effectiveness of a new approach to managing Open Angle Glaucoma (OAG), a condition affecting millions globally.
The trial involved 15 patients who had never undergone filtration surgery before, making it a significant step forward in exploring alternatives for individuals struggling with this chronic eye disease. Each participant received the VisiPlate® device through a one-time surgical procedure, providing a fresh perspective on glaucoma management.
Key Findings from the VITA Trial
After 12 months post-implantation, the results were indeed remarkable. Patients’ average intraocular pressure (IOP) dropped significantly from a baseline of 24.1 ± 6.2 mmHg to just 13.1 ± 2.6 mmHg. This translates to a staggering 42.6% reduction in diurnal IOP, a critical measure for assessing glaucoma control. Notably, those who previously relied on multiple medications to manage their condition saw a decrease in their medication regimen from an average of 2.0 ± 1.5 to just 1.3 ± 1.5 medications.
Perhaps most encouraging, nearly 47% of participants no longer required any glaucoma medication at the 12-month mark, highlighting the potential of the VisiPlate® to diminish the burden of daily eye drops for many patients.
Importantly, the study reported no serious adverse events, reassuring both patients and clinicians about the safety of this new technology. Vision stability was maintained, with none of the participants experiencing persistent vision loss—a common concern in surgical interventions related to eye health.
With these positive outcomes, the VisiPlate® device could be a game-changer in the field of ophthalmology, providing hope and improved quality of life for those affected by glaucoma. As Avisi Technologies continues to gather data and push forward with their innovative solutions, the future looks brighter for glaucoma patients.
For more insights on advancements in the medical field that are transforming lives, stay tuned to Africazine.
#SouthAfrica #WorldNews #HealthTech #Innovation
